Prathyusha Duraibabu
Chief Financial Officer
Other
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Sangamo Therapeutics, Inc (SGMOQ) | Chief Financial Officer | $483,960 | $1,186,045 |
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | Senior Vice President, Chief Financial Officer | $483,960 | $1,057,465 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | Senior Vice President, Chief Financial Officer | $436,000 | $1,293,430 |
| 2021 | Sangamo Therapeutics, Inc (SGMOQ) | Senior Vice President, Chief Financial Officer | $362,586 | $1,056,750 |
Executive changes
Earnings-call appearances
-
Sangamo Therapeutics, Inc Q3 FY2025 Earnings Call2025-11-06
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q2 FY2025 Earnings Call2025-08-07
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q3 FY2024 Earnings Call2024-11-12
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q3 FY2023 Earnings Call2023-11-01
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q2 FY2023 Earnings Call2023-08-08
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q1 FY2023 Earnings Call2023-04-26
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q4 FY2022 Earnings Call2023-02-22
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q3 FY2022 Earnings Call2022-11-03
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q2 FY2022 Earnings Call2022-08-04
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q1 FY2022 Earnings Call2022-05-05
Sangamo Therapeutics, Inc (SGMOQ)